Cellyan Biotechnology Co., Ltd
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company incorporated in the Cayman Islands in 2023 with operational roots established in 2016, serves as a leading provider of over-the-counter (OTC) pharmaceutical cross-border e-commerce supply chain services and procurement and distribution solutions, primarily operating through its Hong Kong subsidiaries Joint Cross Border and V-Alliance; the company delivers comprehensive one-stop services including OTC product wholesale, GSP-certified multi-temperature warehousing, pharmaceutical logistics and transportation, import/export customs clearance, drug enlisting with the Hong Kong Department of Health, packaging, supply chain analysis and optimization, real-time temperature monitoring, and end-to-end delivery for merchants, e-commerce platform logistics partners, pharmaceutical distributors, and consumers in Hong Kong and Mainland China. Headquartered at Room B1, 5/F, Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong, the company facilitates the transport of medicines from global sources to Hong Kong storage facilities and onward cross-border transfers to Mainland China via e-commerce channels, maintaining certifications such as GSP qualification, Hong Kong government approvals, ISO quality management, and vehicle compliance. In recent developments, Hong Kong Pharma Digital Technology Holdings Limited completed its initial public offering on the NASDAQ under ticker HKPD in January 2025, raising $6.0 million by pricing 1.5 million shares at $4.00, followed by ringing the Opening Bell; in February 2025, it formed a strategic partnership with a leading technology-driven Chinese e-commerce platform to enhance cross-border logistics, order fulfillment, and warehouse management services; additionally, the company announced its 2025 Equity Incentive Plan and scheduled its annual general meeting for December 12, 2025.
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
Hong Kong Pharma Digital Technology (NASDAQ:HKPD) Stock Price Up 0.3% – Here’s What Happened
DCS Announces Q3 2025 Quarterly Financial Statements
Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024
U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering